Kyle Oh
Physical Medicine & Rehabilitation · Kirkland, WANPI 1699847590
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.3% of the total across 156 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $679, 2.6 times the $258 reported in 2019. Among physical medicine & rehabilitation clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 156 payments — averaging $20.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Orexo US, Inc.$634
- Collegium Pharmaceutical, Inc.$564
- AbbVie$442
- Titan Pharmaceuticals, Inc.$437
- Pfizer$315
- Lilly USA, LLC$234
- plus $604 from 15 others
What the payments were for
- Consulting fees$2508%
- Food & beverage$2,98192%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Orexo US, Inc. | 40 | $634 |
| Collegium Pharmaceutical, Inc. | 28 | $564 |
| AbbVie(2 entities) | 30 | $442 |
| Titan Pharmaceuticals, Inc. | 9 | $437 |
| Pfizer | 11 | $315 |
| Lilly USA, LLC | 11 | $234 |
| Indivior Inc. | 5 | $85 |
| Amgen | 3 | $72 |
| Daiichi Sankyo Inc. | 4 | $68 |
| Boston Scientific | 1 | $57 |
| Virtus Pharmaceuticals LLC | 2 | $55 |
| Si-bone, Inc. | 1 | $52 |
| Idorsia Pharmaceuticals US Inc | 2 | $37 |
| Redhill Biopharma Inc. | 2 | $34 |
| Braeburn Inc. | 1 | $28 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $25 |
| Eisai Inc. | 1 | $24 |
| Medtronic | 1 | $24 |
| Protega Pharmaceutials Inc | 1 | $17 |
| Abbott | 1 | $14 |
| Biodelivery Sciences International, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Probuphine$250
How this compares
$3,231 in reported general payments places this provider in the 90th percentile of 260 physical medicine & rehabilitation providers in Washington.
See all physical medicine & rehabilitation providers in Washington →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 1,972 | $44,384 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 670 | $30,396 |
| Xtampza ErOxycodone Myristate | 28 | $15,844 |
| Morphine Sulfate ErMorphine Sulfate | 499 | $11,424 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 67 | $10,455 |
| Buprenorphine Hcl | 241 | $9,950 |
| Fentanyl | 68 | $7,536 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 159 | $7,318 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 74 | $6,568 |
| ZubsolvBuprenorphine Hcl/Naloxone Hcl | 11 | $5,258 |
| Sumatriptan | 12 | $5,258 |
| Hydromorphone Hcl | 271 | $5,011 |
| Gabapentin | 243 | $4,403 |
| Tramadol Hcl | 224 | $3,010 |
| Methocarbamol | 125 | $2,631 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $564 | $15,84428 claims |
| Orexo US, Inc.Zubsolv | $634 | $5,25811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 260 physical medicine & rehabilitation providers in Washington.
Other physical medicine & rehabilitation in Kirkland
- Theodore BrownKirkland$62K
- Yung LeeKirkland$5K
- Matthew LacourseKirkland$3K
- Ryan ZehnderKirkland$2K
- Nassim RadSeattle$231K
- Nelson HagerTacoma$186K
- Martin ChildersSeattle$170K
- Angeli MayadevSeattle$51K
- Ronan CahillBellevue$22K
- Karen StanekSpokane$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.